Conflicts of Interest Among Infectious Diseases Clinical Practice Guideline Authors and the Pharmaceutical Industry

Aileen S Ahiskali; Dimitri M Drekonja; Jonathan D Alpern

doi:10.1001/jamanetworkopen.2023.8592

Conflicts of Interest Among Infectious Diseases Clinical Practice Guideline Authors and the Pharmaceutical Industry

JAMA Netw Open. 2023 Apr 3;6(4):e238592. doi: 10.1001/jamanetworkopen.2023.8592.

Authors

Aileen S Ahiskali¹, Dimitri M Drekonja^{2

3}, Jonathan D Alpern^{2

3

4}

Affiliations

¹ Department of Pharmacy, Hennepin Healthcare, Minneapolis, Minnesota.
² Infectious Diseases Section, Minneapolis Veterans Affairs Healthcare System, Minneapolis, Minnesota.
³ Department of Medicine, University of Minnesota, Minneapolis.
⁴ Department of Infectious Diseases, HealthPartners, Minneapolis, Minnesota.

No abstract available

Plain language summary

This cross-sectional study assesses the prevalence of conflicts of interest (COI) associated with guideline-recommended drugs among Infectious Diseases Society of America clinical practice guideline authors and compliance with the Council on Medical Specialty Societies and Institute of Medicine guidelines.

MeSH terms

Conflict of Interest*
Drug Industry
Humans
Medicine*